Torray LLC Amgen Inc Transaction History

Torray LLC

$678 Million
Q3 2024

A detailed history of Torray LLC transactions in Amgen Inc stock. As of the latest transaction made, Torray LLC holds 12,158 shares of AMGN stock, worth $3.23 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

12,158

Previous 15,257 20.31%

Holding current value

$3.23 Million

Previous $4.77 Million 17.83%

% of portfolio

0.58%

Previous 0.74%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $958,768 - $1.05 Million	-3,099 Reduced 20.31%	12,158 $3.92 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $27,326 - $33,208	104 Added 0.69%	15,257 $4.77 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $2.91 Million - $3.51 Million	-10,819 Reduced 41.66%	15,153 $4.31 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $3.26 Million - $3.94 Million	12,141 Added 87.78%	25,972 $7.38 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $140,379 - $158,364	-549 Reduced 3.82%	13,831 $3.98 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $116,103 - $144,145	531 Added 3.83%	14,380 $3.86 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $719,947 - $851,323	3,360 Added 32.03%	13,849 $3.07 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $171,826 - $209,427	761 Added 7.82%	10,489 $2.54 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $195,362 - $248,231	-853 Reduced 8.06%	9,728 $2.55 Million
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $588,534 - $663,759	-2,622 Reduced 19.86%	10,581 $2.39 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $410,433 - $456,740	-1,779 Reduced 11.87%	13,203 $3.21 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $182,871 - $202,303	834 Added 5.89%	14,982 $3.62 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $758,926 - $868,521	3,816 Added 36.93%	14,148 $3.18 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $270,007 - $316,346	1,272 Added 14.04%	10,332 $2.2 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $150,425 - $166,886	644 Added 7.65%	9,060 $2.21 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $78,999 - $92,061	356 Added 4.42%	8,416 $2.09 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $222,005 - $264,369	1,026 Added 14.59%	8,060 $1.85 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $11,497 - $12,786	49 Added 0.7%	7,034 $1.79 Million
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $296,121 - $363,381	-1,497 Reduced 17.65%	6,985 $1.65 Million
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $598,111 - $793,259	-3,282 Reduced 27.9%	8,482 $1.72 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $53,168 - $68,339	-281 Reduced 2.33%	11,764 $2.84 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $7,486 - $8,970	43 Added 0.36%	12,045 $2.33 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $266,053 - $311,874	1,596 Added 15.34%	12,002 $2.21 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $90,615 - $102,143	501 Added 5.06%	10,406 $1.98 Million
Q4 2018 Feb 06, 2019	SELL	$178.4 - $208.25 $309,702 - $361,522	-1,736 Reduced 14.91%	9,905 $1.93 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $165,278 - $186,329	892 Added 8.3%	11,641 $2.41 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $262,192 - $294,499	1,579 Added 17.22%	10,749 $1.98 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $144,693 - $169,092	854 Added 10.27%	9,170 $1.56 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $451,175 - $504,101	2,673 Added 47.37%	8,316 $1.45 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $944,017 - $1.08 Million	5,643	5,643 $1.05 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.

Account